May 2, 2017 / 9:41 PM / in 2 years

Roche wins reversal of $25 million verdict for Accutane user

A New Jersey appellate court on Tuesday overturned for a second time a $25 million verdict for an Alabama man who claimed Hoffmann-La Roche’s acne drug Accutane caused him to develop bowel disease that ultimately required his colon to be removed.

A three-judge panel of the Superior Court of New Jersey’s Appellate Division ruled that a lower-court judge erred in excluding an expert witness Roche wanted to call at trial whose testimony would have overlapped with another expert.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below